Literature DB >> 2142394

Endometrial hyperplasia: a prospective randomized study of histopathology, tissue steroid receptors and plasma steroids after abrasio, with or without high dose gestagen treatment.

B Lindahl1, P Alm, M Fernö, A Norgren.   

Abstract

274 patients with spontaneous endometrial hyperplasias were randomized into two groups: one treated with only abrasio, and another with additional 500 mg medroxyprogesterone acetate (MPA) twice weekly for 3 months. Total disappearance of all types of hyperplasias was seen following MPA treatment, whereas with only abrasio about 60% were removed suggesting that MPA does not have to be generally given to eliminate endometrial hyperplasias. Quantitative determinations of tissue steroid receptors and plasma steroids do not seem to be useful for the selection of patients in need of gestagen treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142394

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia.

Authors:  Fariba Behnamfar; Attaollah Ghahiri; Marzieh Tavakoli
Journal:  J Res Med Sci       Date:  2014-08       Impact factor: 1.852

2.  Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial.

Authors:  A Orbo; Ab Vereide; M Arnes; I Pettersen; B Straume
Journal:  BJOG       Date:  2013-11-28       Impact factor: 6.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.